Sanofi Pasteur Presents Phase III Data for Investigational Quadrivalent Influenza Vaccine

Sanofi Pasteur, the vaccines division of Sanofi, presented an overview of Phase II and Phase III clinical trials for its investigational quadrivalent influenza vaccine.
4-Traders